PrEP and PEP: Prevention of HIV Topical Map
Complete topic cluster & semantic SEO content plan — 32 articles, 5 content groups ·
Build a definitive resource that covers clinical science, practical access, adherence and risk-reduction, and special-population guidance for PrEP and PEP. The strategy is to create deep pillar articles for each sub-theme supported by focused cluster pages (protocols, assistance programs, side-effect management, legal/consent issues, and scenario-specific guidance) so the site becomes the authoritative destination for both patients and clinicians.
This is a free topical map for PrEP and PEP: Prevention of HIV. A topical map is a complete topic cluster and semantic SEO strategy that shows every article a site needs to publish to achieve topical authority on a subject in Google. This map contains 32 article titles organised into 5 topic clusters, each with a pillar page and supporting cluster articles — prioritised by search impact and mapped to exact target queries.
How to use this topical map for PrEP and PEP: Prevention of HIV: Start with the pillar page, then publish the 20 high-priority cluster articles in writing order. Each of the 5 topic clusters covers a distinct angle of PrEP and PEP: Prevention of HIV — together they give Google complete hub-and-spoke coverage of the subject, which is the foundation of topical authority and sustained organic rankings.
📋 Your Content Plan — Start Here
32 prioritized articles with target queries and writing sequence. Want every possible angle? See Full Library (81+ articles) →
Foundations: What PrEP and PEP are and how they work
Explains basic definitions, biology, effectiveness, differences between PrEP and PEP, and common misconceptions — essential reading for anyone new to HIV prophylaxis.
PrEP and PEP: A complete guide to HIV prevention
This pillar defines PrEP and PEP, explains mechanisms of action, compares effectiveness, summarizes recommended drugs and dosing, and addresses common myths and resistance concerns. Readers gain a clear, evidence-based understanding of when each strategy is appropriate and what outcomes to expect.
How PrEP works: the science and evidence
Explains pharmacology, tissue drug levels, pharmacokinetics for sexual and injection exposures, and summarizes major trials and cohort studies demonstrating PrEP effectiveness.
How PEP works: timing, window period, and evidence
Covers the critical 72-hour window for PEP initiation, typical regimens, evidence supporting post-exposure use, and expected effectiveness by exposure type.
PrEP vs PEP: when to use each HIV prevention strategy
Direct comparison with real-world scenarios (e.g., condom failure, occupational exposure, sexual assault, ongoing risk) to help readers choose or seek the right intervention.
Effectiveness of PrEP and PEP: studies, statistics, and limitations
Summarizes randomized trials, open-label studies, observational data, and metrics like relative risk reduction and number-needed-to-treat; discusses gaps and population variability.
HIV resistance and PrEP/PEP: how big is the risk?
Explains when resistance occurs, how to minimize risk (baseline testing, adherence), and clinical consequences if breakthrough infection happens on prophylaxis.
Clinical guidance and prescribing protocols
Detailed, clinician-focused guidance on assessing eligibility, laboratory monitoring, recommended regimens, and follow-up for safe and effective PrEP and PEP prescribing.
Clinical guidelines for prescribing PrEP and PEP
A step-by-step clinical reference covering patient selection, baseline evaluation, recommended laboratory testing, drug choices and dosing, monitoring schedules, and when to refer to specialists. It’s designed to be a practical, guideline-aligned resource for clinicians and advanced practice providers.
Eligibility criteria for PrEP: who should be offered it
Defines behavioral, partner-based, and clinical risk factors that indicate PrEP, and walks through using screening tools (e.g., risk checklists) in primary care.
PEP clinical protocol: steps for clinicians (72-hour window, regimens)
Action checklist for emergency departments and clinics: assessing exposure, baseline testing, selecting PEP regimen, and arranging follow-up.
Baseline and follow-up testing for PrEP: labs, frequency, and interpretation
Specifies required baseline labs (HIV, creatinine, hepatitis B/C, pregnancy), follow-up schedule, and how to act on abnormal results.
Drug interactions and contraindications for PrEP and PEP
Summarizes important interactions (e.g., nephrotoxic drugs, some anticonvulsants), contraindications, and resources for checking interactions in complex patients.
Managing PrEP in pregnancy and breastfeeding: clinical considerations
Reviews safety data, counseling points, and monitoring recommendations for pregnant or breastfeeding people considering PrEP.
Stopping, switching, and restarting PrEP: clinical scenarios
Guidance on discontinuation, switching between agents (TDF vs TAF), and how to safely restart after gaps in use or after potential exposure.
Access, cost, and getting PrEP/PEP
Practical guidance on how to obtain PrEP and PEP: costs, insurance coverage, assistance programs, clinic options, telemedicine, and confidentiality concerns.
How to access PrEP and PEP: cost, insurance, and assistance programs
A practical guide for patients and navigators detailing cost components, insurance coverage strategies, manufacturer assistance (Truvada and Descovy programs), public health options, telemedicine services, and how to find clinics that provide confidential care. Readers will know exactly where and how to get medication quickly and affordably.
PrEP assistance programs and manufacturer coupons (Truvada, Descovy)
Step-by-step instructions on applying for manufacturer assistance, eligibility, paperwork, and alternative local programs to reduce or eliminate out-of-pocket costs.
Does insurance cover PrEP? Using private insurance and Medicaid
Explains typical coverage patterns, tips for reducing copays, handling prior authorizations, and Medicaid policies by state (high-level overview).
Telemedicine and online PrEP services: how they work
Describes telehealth workflows, home lab options, turnaround times, costs, and reputable online providers to consider.
Where to get PEP after exposure: ERs, clinics, and urgent care
Actionable guidance for people who need PEP now: where to go, what to expect at the visit, and how to speed care.
Confidentiality and minors: can adolescents get PrEP without parental consent?
Explains minor consent laws by jurisdiction, ways to preserve confidentiality, and resources for teens seeking PrEP.
Adherence, side effects, and ongoing sexual-health care
Focuses on maintaining protection: adherence strategies, side-effect management, monitoring kidney/bone health, and integration of STI screening and safer-sex counseling.
Staying safe on PrEP and PEP: adherence, side effects, and sexual health practices
This pillar advises patients and clinicians on recognizing and managing side effects, strategies to maximize adherence (daily vs on-demand), monitoring for renal and bone issues, and maintaining STI prevention and testing routines while using PrEP/PEP.
Daily vs on‑demand PrEP (2-1-1): who should use which method
Explains 2-1-1 dosing step-by-step, evidence for its use in cisgender MSM and transgender women, and practical considerations when choosing a regimen.
Managing common PrEP side effects: nausea, kidney function, and bone health
Practical advice for patients and clinicians on expected side effects, when to reassure versus test, and referrals for specialty care when needed.
Adherence tools and support: reminders, pharmacies, and peer programs
Describes apps, pillboxes, pharmacy synchronization, text reminders, and community-based adherence support that improve persistence on PrEP.
Risk compensation and STI prevention while on PrEP
Examines data on behavioral change after starting PrEP, strategies to maintain condom use when desired, and intensified STI screening approaches.
Alcohol, recreational drugs, and PrEP: safety and interaction guidance
Summarizes evidence around alcohol and common recreational drugs and whether they modify PrEP safety or efficacy; practical harm-reduction tips.
Special populations and real-world scenarios
Addresses tailored guidance for adolescents, transgender people, PWID, pregnant/breastfeeding people, sexual assault survivors, serodiscordant couples, and occupational exposures.
PrEP and PEP for special populations: adolescents, transgender people, PWID, pregnancy, and survivors of sexual assault
Comprehensive coverage of population-specific evidence, dosing and monitoring nuances, consent and access barriers, and culturally competent counseling for groups with unique needs. Clinicians and community organizations will find practical, evidence-based guidance to deliver appropriate prophylaxis.
PrEP for transgender people: interactions with gender-affirming hormones and care considerations
Reviews pharmacokinetic data, evidence on efficacy and safety, recommended counseling, and culturally competent service delivery for transgender clients.
PrEP for adolescents: consent laws, clinic models, and youth-friendly care
Explains legal frameworks for minor consent, best practices for confidentiality, school- and community-based delivery models, and tailoring adherence support for youth.
PrEP and PEP for people who inject drugs (PWID): integration with harm-reduction services
Guidance on delivering prophylaxis through syringe service programs, addressing dual risks of injection and sexual exposure, and monitoring needs.
PrEP during pregnancy and breastfeeding: benefits, risks, and monitoring
Summarizes safety data for fetal and infant outcomes, when to continue or start PrEP in pregnancy, and guidance for breastfeeding individuals.
PEP after sexual assault: protocols, timing, and survivor-centered care
Stepwise guidance for emergency responders and advocates: urgent clinical care, forensic considerations, trauma-informed counseling, and linkage to follow-up services.
Serodiscordant couples and conception: using PrEP, PEP, and TasP to reduce transmission
Options for safer conception including timing, PrEP use for the uninfected partner, antiretroviral therapy and viral suppression for the positive partner, and assisted reproductive technologies.
📚 The Complete Article Universe
81+ articles across 9 intent groups — every angle a site needs to fully dominate PrEP and PEP: Prevention of HIV on Google. Not sure where to start? See Content Plan (32 prioritized articles) →
TopicIQ’s Complete Article Library — every article your site needs to own PrEP and PEP: Prevention of HIV on Google.
Strategy Overview
Build a definitive resource that covers clinical science, practical access, adherence and risk-reduction, and special-population guidance for PrEP and PEP. The strategy is to create deep pillar articles for each sub-theme supported by focused cluster pages (protocols, assistance programs, side-effect management, legal/consent issues, and scenario-specific guidance) so the site becomes the authoritative destination for both patients and clinicians.
Search Intent Breakdown
👤 Who This Is For
IntermediateClinics, sexual health publishers, public health NGOs, telehealth startups, and experienced health bloggers aiming to build a comprehensive HIV prevention resource for both patients and clinicians.
Goal: Within 12 months rank for core transactional and informational queries (e.g., 'how to get PrEP near me', 'PEP after exposure'), drive clinic referrals/telehealth leads, and become an authoritative resource cited by regional health services and community organizations.
First rankings: 3-6 months
💰 Monetization
High PotentialEst. RPM: $8-$25
Best monetization mixes clinical lead-gen (telehealth referrals, local clinic partnerships) with sponsored public-health content and grants; direct-to-consumer ad revenue supplements but is secondary due to medical trust requirements.
What Most Sites Miss
Content gaps your competitors haven't covered — where you can rank faster.
- Localized, step-by-step guides to access PrEP/PEP by country, state, or province (including exact clinic lists, telehealth options, and lab logistics) — most sites remain generic.
- Practical navigation of insurance, manufacturer assistance, and patient assistance programs with downloadable checklists and sample paperwork for uninsured or underinsured patients.
- Detailed PEP-to-PrEP transition protocols, including timing of tests, drug interactions, and how to manage incomplete PEP adherence before starting PrEP.
- Scenario-specific guidance for populations with unique needs: pregnancy and conception in serodiscordant couples, transgender individuals (hormone interactions), adolescents (consent/confidentiality), and people who inject drugs.
- Operational implementation content for clinicians and clinics: workflow templates, lab-order sets, billing codes, standing orders, and population-level PrEP scale-up playbooks.
- Long-term safety and monitoring deep dives — bone health, renal monitoring thresholds, switching algorithms between TDF, TAF, and injectable cabotegravir, and pregnancy considerations.
- Behavioral adherence interventions and real-world case studies: digital adherence tools, community-based peer support programs, and metrics that move adherence, not just pill counts.
- Legal/ethical content often missing: consent/guardian issues for minors, confidentiality in electronic records, partner notification nuances, and workplace/discrimination protections related to PrEP use.
Key Entities & Concepts
Google associates these entities with PrEP and PEP: Prevention of HIV. Covering them in your content signals topical depth.
Key Facts for Content Creators
Daily oral TDF/FTC PrEP reduces HIV acquisition risk by more than 90% with high adherence for receptive anal sex.
Highlighting efficacy signals the clinical value of PrEP content and supports pages on adherence strategies and evidence summaries.
PEP must be initiated within 72 hours of exposure and is prescribed as a 28-day antiretroviral course with scheduled testing.
This urgent-timeline stat supports content that needs clear CTAs and local access pathways for emergency care and telehealth.
Global new HIV infections were roughly 1.5 million in 2021 (UNAIDS), underscoring prevention needs.
Use global burden figures to justify public-health oriented content, grant-focused resources, and country-specific access guides.
In many high-income settings only about 20–30% of people clinically indicated for PrEP are receiving it, with substantial racial and geographic disparities.
This coverage gap supports content focused on equity, navigation of assistance programs, and outreach strategies to underserved populations.
Long-acting injectable cabotegravir (Apretude) was approved for HIV PrEP and offers dosing every two months after initiation.
Regulatory and product updates are search drivers; coverage comparisons (oral vs injectable) and clinic implementation guides are high-value content.
Common Questions About PrEP and PEP: Prevention of HIV
Questions bloggers and content creators ask before starting this topical map.
Why Build Topical Authority on PrEP and PEP: Prevention of HIV?
Building topical authority on PrEP and PEP positions a site at the intersection of preventive medicine, public health, and patient navigation — a high-traffic, high-impact niche with substantial clinical and commercial value. Dominance requires deep, locally actionable resources (access pathways, payer navigation, clinician implementation), which creates durable referral traffic, partnership opportunities with health services, and high trust signals that search engines and clinicians prioritize.
Seasonal pattern: Year-round with small peaks around Pride month (June), World AIDS Day (December 1), and back-to-school months for youth-focused outreach (August–September); evergreen clinical demand otherwise.
Content Strategy for PrEP and PEP: Prevention of HIV
The recommended SEO content strategy for PrEP and PEP: Prevention of HIV is the hub-and-spoke topical map model: one comprehensive pillar page on PrEP and PEP: Prevention of HIV, supported by 27 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on PrEP and PEP: Prevention of HIV — and tells it exactly which article is the definitive resource.
32
Articles in plan
5
Content groups
20
High-priority articles
~6 months
Est. time to authority
Content Gaps in PrEP and PEP: Prevention of HIV Most Sites Miss
These angles are underserved in existing PrEP and PEP: Prevention of HIV content — publish these first to rank faster and differentiate your site.
- Localized, step-by-step guides to access PrEP/PEP by country, state, or province (including exact clinic lists, telehealth options, and lab logistics) — most sites remain generic.
- Practical navigation of insurance, manufacturer assistance, and patient assistance programs with downloadable checklists and sample paperwork for uninsured or underinsured patients.
- Detailed PEP-to-PrEP transition protocols, including timing of tests, drug interactions, and how to manage incomplete PEP adherence before starting PrEP.
- Scenario-specific guidance for populations with unique needs: pregnancy and conception in serodiscordant couples, transgender individuals (hormone interactions), adolescents (consent/confidentiality), and people who inject drugs.
- Operational implementation content for clinicians and clinics: workflow templates, lab-order sets, billing codes, standing orders, and population-level PrEP scale-up playbooks.
- Long-term safety and monitoring deep dives — bone health, renal monitoring thresholds, switching algorithms between TDF, TAF, and injectable cabotegravir, and pregnancy considerations.
- Behavioral adherence interventions and real-world case studies: digital adherence tools, community-based peer support programs, and metrics that move adherence, not just pill counts.
- Legal/ethical content often missing: consent/guardian issues for minors, confidentiality in electronic records, partner notification nuances, and workplace/discrimination protections related to PrEP use.
What to Write About PrEP and PEP: Prevention of HIV: Complete Article Index
Every blog post idea and article title in this PrEP and PEP: Prevention of HIV topical map — 81+ articles covering every angle for complete topical authority. Use this as your PrEP and PEP: Prevention of HIV content plan: write in the order shown, starting with the pillar page.
Informational Articles
- What Are PrEP and PEP? Clear Definitions and Key Differences
- How PrEP Works: The Pharmacology Behind HIV Prevention
- How PEP Works: Timing, Mechanism, and Why Speed Matters
- History of HIV Prevention: The Development of PrEP and PEP
- Common Side Effects of PrEP and PEP: What To Expect and When To Seek Care
- Drug Interactions With PrEP and PEP: What Clinicians and Patients Must Know
- How Long Does PrEP Protect You? Onset, Duration, and Gaps in Coverage
- Cost and Insurance Basics for PrEP and PEP: Out-Of-Pocket, Assistance, and Formularies
- PrEP and PEP Myths Versus Facts: Correcting Common Misconceptions
Treatment / Solution Articles
- Initiating Daily Oral PrEP: A Clinician's Step-by-Step Protocol
- On-Demand (Event-Driven) PrEP: Dosing Guide, Evidence, and Practical Use Cases
- Emergency PEP Regimen: 72-Hour Window, Drug Choices, and Follow-Up Plan
- Switching From Oral PrEP To Long-Acting Cabotegravir: Indications And Transition Plan
- Managing PrEP-Related Renal Function Changes: Monitoring and Dose Adjustment
- PrEP During Pregnancy and Breastfeeding: Risks, Benefits, and Clinical Recommendations
- Managing Side Effects to Maintain PrEP Adherence: Clinical Strategies and Patient Scripts
- PrEP and Hepatitis B: Screening, Vaccination, and Co-Management Protocols
- Occupational PEP for Healthcare Workers: Institutional Protocols and Legal Considerations
Comparison Articles
- Daily Oral PrEP Versus Long-Acting Injectable PrEP: Efficacy, Side Effects, and Real-World Use
- TDF/FTC Versus TAF/FTC for PrEP: Safety, Efficacy, And Renal/Bone Considerations
- PrEP Versus Condoms: Complementary Strategies and When to Use Each
- On-Demand PrEP Versus Daily PrEP: Who Benefits Most From Each Approach
- PEP Regimens Compared: Integrase Inhibitor Versus Protease Inhibitor–Based Options
- Brand Versus Generic PrEP Drugs: Cost, Bioequivalence, And Patient Access
- PrEP Guidelines Compared: CDC, WHO, EACS, And National Variations Summarized
- PrEP Versus PEP for Travelers: Which Prevention Strategy Works for Short-Term Risk?
- Behavioral Interventions Versus Biomedical Interventions: Combining PrEP With Counseling
Audience-Specific Articles
- PrEP for Men Who Have Sex With Men (MSM): Risk Assessment, Dosing Options, And Outreach Strategies
- PrEP Guidance for Trans Women: Hormone Interactions, Access Barriers, And Clinical Best Practices
- PrEP for Cisgender Women: Effectiveness, Contraception Interactions, And Pregnancy Planning
- Adolescent PrEP: Consent Laws, Dosing, And Confidential Care Considerations
- PrEP for People Who Inject Drugs: Harm Reduction Integration and Prescribing Guidance
- PrEP for Serodiscordant Couples Trying To Conceive: Timing, ART, And Safety Protocols
- PrEP for Sex Workers: Outreach Strategies, Clinic Models, and Legal Barrier Navigation
- PrEP Considerations For Older Adults: Comorbidities, Polypharmacy, And Monitoring
- PrEP For Healthcare Workers: Postexposure Prophylaxis Options And Ongoing Prevention
Condition / Context-Specific Articles
- PrEP With Reduced Kidney Function: Adjustments, Alternatives, And Specialist Referral Criteria
- Managing PrEP in Patients With Hepatitis C Co-Infection: Screening And Treatment Coordination
- PEP After Sexual Assault: Trauma-Informed Clinical Workflow And Follow-Up Care
- PrEP and Mental Health Conditions: Assessing Adherence Risks and Integrated Care Pathways
- Using PrEP and PEP During International Travel: Pre-Trip Planning and On-Trip Access
- Chemsex and PrEP: Risk Reduction, Adherence Challenges, And Harm-Reduction Strategies
- PEP After Occupational Needlestick Injury: Stepwise Management and Employer Responsibilities
- PrEP Use in People With HIV Viral Suppression Partners: When Additional Prevention Is Appropriate
- PrEP For People Experiencing Homelessness: Clinic Models, Mobile Services, And Retention Strategies
Psychological / Emotional Articles
- Addressing Stigma Around PrEP: Communication Scripts For Clinicians And Advocates
- Supporting Adherence Motivation: Behavioral Techniques To Help Patients Stay On PrEP
- Counseling After A High-Risk Exposure: Emotional Triage And Clear Messaging For PEP Clients
- Navigating Partner Disclosure About PrEP: Strategies For Safety And Relationship Resilience
- Managing Fear Of Side Effects And Resistance: Reassurance, Education, And Decision Aids
- Trauma-Informed Care For Survivors Seeking PEP: Clinician Checklist And Language To Use
- Addressing Sexual Anxiety After Starting PrEP: Counseling Tips To Maintain Healthy Sexuality
- Building Peer Support Networks For PrEP Users: Models, Moderation, And Best Practices
- Addressing Provider Bias Toward PrEP Candidates: Training Modules And Reflective Practices
Practical / How-To Articles
- How To Start PrEP: Patient Checklist From First Visit To Maintenance
- How To Access Free Or Low-Cost PrEP: Navigating Assistance Programs And Manufacturer Coupons
- Telehealth PrEP Workflow: Virtual Initiation, Labs, And Follow-Up Templates For Clinics
- Laboratory Monitoring Schedule For PrEP: Baseline And Ongoing Tests With Interpretation Tips
- How To Apply For Insurance Coverage For PrEP: Authorization Letters And Coding Tips
- Clinic Start-Up Guide For A PrEP Program: Staffing, Metrics, And Patient Flow
- Adherence Tools And Reminders: Top Apps, Pillboxes, And Behavioral Nudges For PrEP Users
- How To Conduct Risk Assessment For PrEP Eligibility: Questions, Scoring, And Documentation
- Creating A PrEP Follow-Up Plan: Visit Frequency, Lab Reminders, And Retention Strategies
FAQ Articles
- How Fast Does PrEP Start Working? Timeline For Full Protection By Exposure Type
- Can You Use PEP As PrEP? Timing, Safety, And Clinical Recommendations
- What Happens If I Miss A PrEP Dose? Actions To Take And Risk Estimates
- Is PrEP Right For Me If My Partner Is Undetectable? U=U, Risk, And Shared Decision Making
- How Much Does PEP Cost Without Insurance? Emergency Options And Assistance Programs
- Can Adolescents Obtain PrEP Without Parental Consent? Laws By Jurisdiction And Practical Tips
- Will PrEP Affect My Fertility Or Pregnancy Outcome? Evidence Summary For Patients
- Can You Drink Alcohol While On PrEP Or PEP? Safety, Interactions, And Advice
- How Do I Know If PEP Worked? Timeline For Testing And Signs To Watch For
Research / News Articles
- 2024–2026 PrEP Landscape: Regulatory Approvals, Guideline Updates, And Global Implementation Trends
- Long-Acting Injectables For HIV Prevention: Latest Trial Results And Real-World Effectiveness
- Cabotegravir Versus Oral PrEP: Meta-Analysis Of Efficacy, Safety, And Subgroup Outcomes
- Real-World Adherence Studies For PrEP: What Implementation Data Tell Us About Uptake And Retention
- Emerging Prevention Technologies: bNAbs, Vaccines, And Novel Delivery Systems In 2026
- Cost-Effectiveness Of PrEP Strategies: From Individual-Level Use To National Scale-Up Models
- Global PrEP Access Inequities: Country Case Studies And Lessons For Scaling Equitable Programs
- New Resistance Data After PrEP/PEP Use: What The Latest Sequencing Studies Mean For Practice
- Policy Shifts Affecting PrEP Access: Insurance Mandates, Generic Launches, And Public Health Programs
This topical map is part of IBH's Content Intelligence Library — built from insights across 100,000+ articles published by 25,000+ authors on IndiBlogHub since 2017.
Find your next topical map.
Hundreds of free maps. Every niche. Every business type. Every location.